Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Gr ...

| --- | --- | --- | --- | --- | --- | --- | |----------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third Quarter 2021 Results | | | | | | | Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2021 Earnings Conference Call November 8, 2021 8:00 AM ET Company Participants Robert Borchert - Senior Vice President of Investor and Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Credit Suisse Ryan Daniels - William Blair Joshua Raskin - Nephron Research Lisa Gill - JPMorgan Richard Close - Canacco ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2021 Results Earnings Conference Call August 9, 2021 8:00 AM ET Company Participants Robert Borchert - Senior Vice President of Investor and Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President and Chief Operating Officer Conference Call Participants Ryan Daniels - William Blair Josh Raskin - Nephron Research Jailendra Singh - Credit Suisse Richard Close - Canaccord Genuity Sean Wieland - Piper Sandler Lisa Gill - J.P. Morgan O ...

| --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2021 financial guidance and other projections and forecasts. These f ...

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2021 Earnings Conference Call May 27, 2021 5:00 PM ET Company Participants Robert Borchert - Senior Vice President of Investor & Corporate Communications Shawn Morris - Chief Executive Officer Parth Mehrotra - President & Chief Operating Officer Conference Call Participants Lisa Gill - JP Morgan Jailendra Singh - Credit Suisse Sandy Draper - Truist Securities Ryan Daniels - William Blair Josh Raskin - Nephron Research Richard Close - Canaccord Genuity Jessica Tassa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, ...